| Financial Year |
March 31 2022 |
| Monetary Funds |
383,422,741.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,416,722.98 |
| Accounts Receivable |
942,119,052.13 |
| Advances to Suppliers |
218,320,910.66 |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
718,115,879.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,659,047.01 |
| Total Current Assets |
2,412,352,021.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
948,520.61 |
| Investment Properties |
-- |
| Fixed Assetes |
107,741,727.91 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,274,519.31 |
| R&D expenses |
-- |
| Goodwill |
2,378,321.70 |
| Long-Term Deferred and Prepaid Expenses |
1,675,456.97 |
| Deferred Income Tax Assets |
22,529,306.73 |
| Other Non-Current Assets |
20,126,717.72 |
| Sub-Total of Non-Current Assets |
185,426,045.99 |
| Total Assets |
2,597,778,067.36 |
| Short-Term Loans |
737,346,312.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
155,260,912.30 |
| Accounts Payable |
368,885,276.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,125,186.05 |
| Taxes Payable |
6,474,087.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,124,115.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
43,206,251.14 |
| Other Current Liabilities |
6,257,500.16 |
| Sub-Total of Current Liabilities |
1,385,961,157.71 |
| Long-term Loans |
157,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
158,190,491.28 |
| Total Liabilities |
1,544,151,648.99 |
| Paid-In Capital(Or Share Stock) |
133,333,334.00 |
| Capital Surplus |
576,810,402.44 |
| Surplus Reserve |
29,209,712.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
300,051,437.81 |
| Minority Stockholder's Interest |
14,221,531.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,039,404,886.55 |
| Owner's Equity（Stockholder's Equity） |
1,053,626,418.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,597,778,067.36 |
